Cypherpunk Technologies Reports $39.4 Million Profit After Zcash Price Surge Drives $46 Million Unrealised Gain
Cypherpunk Technologies reported $39.4 million in second-quarter profit, mainly due to a $46 million unrealised gain from its Zcash holdings as ZEC prices rose. Its Leap Therapeutics unit also secured FDA alignment for a proposed Phase 3 trial of sirexatamab in certain colorectal cancer patients.
Anais





